Details
Stereochemistry | ACHIRAL |
Molecular Formula | C19H29NO5 |
Molecular Weight | 351.4373 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCOC(=O)CC1=CC=C(OCC(=O)N(CC)CC)C(OCC)=C1
InChI
InChIKey=QPUVKSKJCNGSGT-UHFFFAOYSA-N
InChI=1S/C19H29NO5/c1-5-11-24-19(22)13-15-9-10-16(17(12-15)23-8-4)25-14-18(21)20(6-2)7-3/h9-10,12H,5-8,11,13-14H2,1-4H3
Molecular Formula | C19H29NO5 |
Molecular Weight | 351.4373 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
AZD-3043, a short-acting intravenous anesthetic/sedative agent. This drug was initially invented by Theravance and then developed by AstraZeneca as a positive allosteric modulator of the γ-aminobutyric acid type A (GABA(A)) receptor containing a metabolically labile ester moiety. Phase I clinical trials for use this compound in anesthesia was completed in Sweden and the UK, but further development was discontinued.
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26111262
Fifty-three subjects received AZD3043 in infusion rate cohorts of 1, 3, 6, 12, 18, 27, 36, 54, and 81 mg/kg/h.
Route of Administration:
Intravenous
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 08:31:47 GMT 2023
by
admin
on
Sat Dec 16 08:31:47 GMT 2023
|
Record UNII |
372AB76LQL
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
372AB76LQL
Created by
admin on Sat Dec 16 08:31:47 GMT 2023 , Edited by admin on Sat Dec 16 08:31:47 GMT 2023
|
PRIMARY | |||
|
DB12576
Created by
admin on Sat Dec 16 08:31:47 GMT 2023 , Edited by admin on Sat Dec 16 08:31:47 GMT 2023
|
PRIMARY | |||
|
DTXSID601339521
Created by
admin on Sat Dec 16 08:31:47 GMT 2023 , Edited by admin on Sat Dec 16 08:31:47 GMT 2023
|
PRIMARY | |||
|
579494-66-9
Created by
admin on Sat Dec 16 08:31:47 GMT 2023 , Edited by admin on Sat Dec 16 08:31:47 GMT 2023
|
PRIMARY | |||
|
10286834
Created by
admin on Sat Dec 16 08:31:47 GMT 2023 , Edited by admin on Sat Dec 16 08:31:47 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |